Expertise in
6
conditions

Dr. Jigarkumar Parikh

Hematology | Oncology
Wellstar MCG Health
1120 15th St, 
Augusta, GA 
Accepting New Patients
Offers Telehealth
Expertise in
6
conditions
Wellstar MCG Health
1120 15th St, 
Augusta, GA 

Overview

Jigarkumar Parikh is a Hematologist and an Oncologist practicing medicine in Augusta, Georgia.

Dr. Parikh is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Muscle Invasive Bladder Cancer, Upper Tract Urothelial Carcinoma (UTUC), Non-Muscle Invasive Bladder Cancer, Bone Marrow Aspiration, and Endoscopy.

He is actively involved in clinical research, co-authoring 6 peer reviewed articles and participating in 3 clinical trials. Dr. Parikh is currently accepting new patients.

Specialties

Hematology
Oncology

Licenses

Internal Medicine in GA

Hospital Affiliations

Piedmont Augusta Hospital
Washington County Regional Medical Center
Aiken Regional Medical Center
Doctors Hospital
Wellstar Mcg Health, Affiliated With Med Col

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Absolute Total Care South Carolina
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

Wellstar MCG Health
1120 15th St, Augusta, GA 30912
Other Locations
Aiken Regional Medical Centers Inc
302 University Pkwy, Aiken, SC 29801
Georgia Cancer Center
818 Saint Sebastian Way, Ste 400, Augusta, GA 30901

Additional Areas of Focus

Dr. Parikh has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Metastatic Uveal Melanoma
Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Phase 2 Randomized, Double-Blinded, Controlled Study of Tucatinib vs Placebo in Combination With Capecitabine and Trastuzumab in Patients With Pretreated Unresectable Locally Advanced or Metastatic HER2+ Breast Carcinoma
Phase 2 Randomized, Double-Blinded, Controlled Study of Tucatinib vs Placebo in Combination With Capecitabine and Trastuzumab in Patients With Pretreated Unresectable Locally Advanced or Metastatic HER2+ Breast Carcinoma
Enrollment Status: Completed
Publish Date: August 14, 2023
Intervention Type: Drug
Study Drugs: tucatinib, capecitabine, trastuzumab
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial Comparing CB-839 in Combination With Cabozantinib (CB-Cabo) vs. Placebo With Cabozantinib (Pbo-Cabo) in Patients With Advanced or Metastatic Renal Cell Carcinoma (RCC)
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial Comparing CB-839 in Combination With Cabozantinib (CB-Cabo) vs. Placebo With Cabozantinib (Pbo-Cabo) in Patients With Advanced or Metastatic Renal Cell Carcinoma (RCC)
Enrollment Status: Completed
Publish Date: March 20, 2023
Intervention Type: Drug
Study Drugs: CB-839, Cabozantinib
Study Phase: Phase 2
A Phase 1/2 Open-Label Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of Seviteronel in Subjects With Advanced Breast Cancer
A Phase 1/2 Open-Label Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of Seviteronel in Subjects With Advanced Breast Cancer
Enrollment Status: Completed
Publish Date: February 01, 2019
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
View 2 Less Clinical Trials

6 Total Publications

Insights into Clinical Features and Outcomes of Adrenal Cortical Carcinosarcoma.
Insights into Clinical Features and Outcomes of Adrenal Cortical Carcinosarcoma.
Journal: Diagnostics (Basel, Switzerland)
Published: September 09, 2022
Similar Doctors
Expertise in
36
conditions
Expertise in
36
conditions
Referral may be required

Wellstar MCG Health

1120 15th St, 
Augusta, GA 
 (0.1 miles away)
706-721-2171
Languages Spoken:
English, Turkish
See accepted insurances
Accepting New Patients
Offers Telehealth

Abdullah Kutlar is a Hematologist practicing medicine in Augusta, Georgia. Dr. Kutlar is highly rated in 36 conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, Hemolytic Anemia, and Bone Marrow Aspiration. Dr. Kutlar is currently accepting new patients.

Expertise in
22
conditions
Expertise in
22
conditions
Referral may be required

Wellstar MCG Health

1120 15th St, 
Augusta, GA 
 (0.1 miles away)
706-721-2505
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Anand Jillella is a Hematologist practicing medicine in Augusta, Georgia. Dr. Jillella is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Acute Promyelocytic Leukemia, Acute Myeloid Leukemia (AML), Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Jillella is currently accepting new patients.

Expertise in
15
conditions
Expertise in
15
conditions
Referral may be required

Augusta Oncology Associates

820 Saint Sebastian Way Ste 3A, 
Augusta, GA 
 (3.0 miles away)
Languages Spoken:
English, Sign Language, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Sharad Ghamande is an Oncologist practicing medicine in Augusta, Georgia. Dr. Ghamande is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Bladder Reconstruction, and Hernia Surgery. Dr. Ghamande is currently accepting new patients.

Frequently Asked Questions about Dr. Jigarkumar Parikh

How do I make an appointment with Dr. Jigarkumar Parikh?

You can book an appointment with Dr. Jigarkumar Parikh by calling their office at 706-724-6100. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Jigarkumar Parikh a top-rated expert for Muscle Invasive Bladder Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jigarkumar Parikh is classified as an Distinguished expert for Muscle Invasive Bladder Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Jigarkumar Parikh specialize in?

While Dr. Jigarkumar Parikh is a Hematology, they have specific expertise in Muscle Invasive Bladder Cancer, Upper Tract Urothelial Carcinoma (UTUC), and Non-Muscle Invasive Bladder Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Jigarkumar Parikh participate in research or clinical trials?

Yes. Dr. Jigarkumar Parikh has published 6 articles and abstracts on conditions like Muscle Invasive Bladder Cancer. You can view a list of Dr. Jigarkumar Parikh's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Jigarkumar Parikh accept my insurance?

Dr. Jigarkumar Parikh accepts most major insurance plans, including Absolute Total Care South Carolina and Aetna. We recommend calling the office directly at 706-724-6100 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Parikh's expertise for a condition
ConditionClose
    View All 49 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile